Top Stories
Merck will contribute operational data to Evinova’s trial benchmarks, join its product steering committee and receive priority access to new tools under the multi-year agreement.
The startup's V-Link platform recently nabbed an FDA breakthrough device designation for reducing cerebral vasospasm in adults with aneurysmal subarachnoid haemorrhage.
Chief scientific officer Robert Abel told FirstWord that one of the challenges of early drug discovery is choosing which ideas and hypotheses "deserve the time and resources to become experiments."
Abbott will commercialise SimpleScreen exclusively in the US, with the approval triggering a $100-million milestone payment to Freenome.
The PCR assay is designed to distinguish between bacterial vaginosis and Candida vaginitis, conditions with overlapping symptoms that can be misdiagnosed.
Conference News
Findings explored today at the ADLM 2026 meeting29-Jul-2026 at 12:30 PM EDT, by Association for Diagnostic and Laboratory Medicine (ADLM)Newswise — ANAHEIM, CALIF. — Breaking research presented today ...
Brazil seeks validation of the elimination of mother-to-child transmission of hepatitis B - PAHO/WHO | Pan American Health Organization ...
Newswise — West Lafayette, IN (July 28, 2026) - Amplified Sciences, a diagnostic company focused on earlier detection, risk stratification, and monitoring of serious diseases, will present two posters...
The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology.FRANKFURT, Germany and ANAHEIM, Calif., July 28, 2026 /PRNewswire/ -- Ozelle ...
Research presented by Taipei American School student Jeffrey Zi Kang Huang at ESHRE 2026 through an international collaboration among Taiwan IVF Group, Ton Yen General Hospital, and Stanford Universit...
